Sepantronium Bromide (YM155)

Sepantronium Bromide (YM155) is an inhibitor linked to DNA Damage Response and Apoptosis and related signaling programs and related pathway-oriented research. It is especially relevant in apoptosis, autophagy, and cancer models, where defined compound exposure can be linked to checkpoint activation, DNA repair, and genome-stability control and caspase-associated cell-death signaling and survival decisions.

The pathway annotation connects Sepantronium Bromide (YM155) to DNA Damage Response and Apoptosis and related signaling programs, supporting experiments that monitor checkpoint activation, DNA repair, and genome-stability control and caspase-associated cell-death signaling and survival decisions across biochemical, cellular, or phenotypic assay formats. This context is compatible with DNA-repair, checkpoint, and genotoxic-stress assays and apoptosis, viability, and caspase-readout assays, as well as transcriptional, biochemical, or phenotypic comparisons linked to the annotated pathway state. In apoptosis, autophagy, and cancer models, these readouts can be combined with viability, reporter, localization, biochemical conversion, or morphology endpoints to refine experimental interpretation.

Research Applications

• Pathway perturbation studies connected to DNA Damage Response and Apoptosis and related signaling programs
• Concentration-response inhibition and target-dependence studies
• Phenotypic profiling in apoptosis, autophagy, and cancer models
• Combination studies with orthogonal perturbagens

Overall, Sepantronium Bromide (YM155) is well suited to pathway-oriented studies that need a defined compound input for DNA Damage Response and Apoptosis and related signaling programs readouts in apoptosis, autophagy, and cancer models. This profile is suited to mechanistic follow-up, comparative profiling, and assay optimization under defined exposure conditions.